Xuri Cell Expansion System W5 Perfusion & CO2 Mixer 2017

Xuri Cell Expansion System. Cytiva Xuri Cell Expansion System W25 ALT American Laboratory Trading The Xuri™ Cell Expansion System W25 is designed for cell therapy manufacturing applications. 1 Introduction Purpose of this document This document provides an overview of Xuri™ Cell Expansion System W25, general system specifica-tions, a description of the material conformity of the system, and the EC Declaration of conformity.

Purpose of this manual This manual describes the expected intended use of the ReadyToProcess WAVE 25 and the Xuri Cell Expansion System W25, the privacy and security capabilities included, and how these capabilities are configured The Xuri™ Cell Expansion System W25 can be used in a variety of cell culture applications including: • Rapid production of clinical grade T-lymphocytes • Perfusion culture of T-lymphocytes • Perfusion culture of human natural killer cells Fig 1

Cytiva GE Healthcare Xuri Cell Expansion System W2

The Xuri Cell Expansion System W25 delivers an automated, controlled expansion environment for the growth of cell therapies in volumes up to 25 L across research, process development, and manufacturing operations. Purpose of this manual This manual describes the expected intended use of the ReadyToProcess WAVE 25 and the Xuri Cell Expansion System W25, the privacy and security capabilities included, and how these capabilities are configured After a 14 day culture with the Xuri W5, cell concentrations of 1.107cells/mL in a 1L volume have been consistently reached and cells exhibited a.

Xuri™ W25 cell expansion system Product overview and demo YouTube. Cells for autologous or allogeneic cell therapies are cultured inside a single-use Xuri Cellbag™ bioreactor Overview Closed system minimizes risk of cell contamination

Xuri Cell Expansion System W5 with Perfusion & CO2 Mixer. ReadyToProcess™ WAVE™ 25 and the Xuri™ Cell Expansion System W25 The Xuri™ Cell Expansion System W25 can be used in a variety of cell culture applications including: • Rapid production of clinical grade T-lymphocytes • Perfusion culture of T-lymphocytes • Perfusion culture of human natural killer cells Fig 1